Bioter SA Revenue vs. Shares Owned By Insiders
| BIOT Stock | EUR 0.28 0.00 0.00% |
For Bioter SA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioter SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioter SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioter SA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioter SA over time as well as its relative position and ranking within its peers.
Bioter |
Bioter SA Shares Owned By Insiders vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bioter SA's current stock value. Our valuation model uses many indicators to compare Bioter SA value to that of its competitors to determine the firm's financial worth. Bioter SA is rated second in revenue category among its peers. It is rated fifth in shares owned by insiders category among its peers . The ratio of Revenue to Shares Owned By Insiders for Bioter SA is about 5,774 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioter SA's earnings, one of the primary drivers of an investment's value.Bioter Revenue vs. Competition
Bioter SA is rated second in revenue category among its peers. Market size based on revenue of General Contractors industry is currently estimated at about 2.29 Billion. Bioter SA adds roughly 241,000 in revenue claiming only tiny portion of equities under General Contractors industry.
Bioter Shares Owned By Insiders vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Bioter SA |
| = | 241 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Bioter SA |
| = | 41.74 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Bioter Shares Owned By Insiders Comparison
Bioter SA is currently under evaluation in shares owned by insiders category among its peers.
Bioter SA Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bioter SA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bioter SA will eventually generate negative long term returns. The profitability progress is the general direction of Bioter SA's change in net profit over the period of time. It can combine multiple indicators of Bioter SA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bioter S.A. operates as a construction company in Greece and internationally. The company was founded in 1962 and is based in Athens, Greece. BIOTER S is traded on Athens Stock Exchange in Greece.
Bioter Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bioter SA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioter SA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioter SA's important profitability drivers and their relationship over time.
Use Bioter SA in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioter SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioter SA will appreciate offsetting losses from the drop in the long position's value.Bioter SA Pair Trading
Bioter SA Pair Trading Analysis
The ability to find closely correlated positions to Bioter SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioter SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioter SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioter SA to buy it.
The correlation of Bioter SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioter SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioter SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioter SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bioter SA position
In addition to having Bioter SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Disruptive Technologies Thematic Idea Now
Disruptive Technologies
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 64 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bioter Stock Analysis
When running Bioter SA's price analysis, check to measure Bioter SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioter SA is operating at the current time. Most of Bioter SA's value examination focuses on studying past and present price action to predict the probability of Bioter SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioter SA's price. Additionally, you may evaluate how the addition of Bioter SA to your portfolios can decrease your overall portfolio volatility.